Details of the Drug | DrugMAP

General Information of Drug (ID: DMURMY1)

Drug Name

Isoxsuprine

Indication

Disease Entry	ICD 11	Status	REF
Raynaud disease	BD42.0	Approved	[1]
Cerebrovascular disease	8B2Z	Withdrawn from market	[2]
Vascular disease	BE2Z	Investigative	[3]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C18H23NO3
Canonical SMILES: CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O
InChI: 1S/C18H23NO3/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15/h3-11,13-14,18-21H,12H2,1-2H3
InChIKey: BMUKKTUHUDJSNZ-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 3783
ChEBI ID: CHEBI:91855
CAS Number: 395-28-8
TTD ID: D0O8OB

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon. Eur J Clin Pharmacol. 1981;20(5):329-33.
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3	Prognostic value of initial blood viscosity on vascular surgery and treatment in peripheral disease. Angiology. 1981 Apr;32(4):230-5.